To study the impact of meconium aspiration on the biosynthesis of prostaglandins and nitric oxide, we investigated the effects of intratracheal meconium instillation on the expression of cyclooxygenase-1 (COX-1) and -2 (COX-2) and endothelial (NOS-3) and inducible (NOS-2) nitric oxide synthase in rat lungs. Anesthetized, tracheotomized, and ventilated rats received 3 mL/kg human meconium suspension intratracheally (n ϭ 19), and 14 control rats received an equal volume of saline. Ten rats were pretreated with indomethacin, and 13 rats were pretreated with dexamethasone. The lungs were ventilated with 70% oxygen for 3 h after the insult, and the level of COX-1, COX-2, NOS-2, and NOS-3 mRNA in lung tissue was analyzed by Northern blot hybridization. Furthermore, the expression and localization of the enzyme proteins was analyzed by immunohistochemistry. COX-1 and NOS-3 were clearly expressed in the lungs of control rats, whereas the level of COX-2 and NOS-2 expression was minimal. Meconium administration did not affect the expression of COX-1, but COX-2 expression was upregulated in the respiratory epithelium and alveolar macrophages. Meconium also induced up-regulation of NOS-2 in the pulmonary epithelium, vascular endothelium, and macrophages. Indomethacin pretreatment did not affect the enzyme expressions, whereas dexamethasone administration significantly inhibited the meconium-induced COX-2 and NOS-2 up-regulation. Our data thus indicate that intrapulmonary meconium upregulates lung COX-2 and NOS-2 gene expression, suggesting an important role for prostaglandins and nitric oxide in the meconium aspiration-induced pulmonary inflammation and hemodynamic changes. Aspiration of meconium frequently causes a severe neonatal disorder, characterized by initial airway obstruction with subsequent alveolocapillary injury and ventilation/perfusion mismatching in the lungs (1). In a few hours, the initial insult is followed by an inflammatory reaction in the lungs with neutrophil accumulation and concomitant increase in the pulmonary vascular resistance (1-4). The pathogenetic mechanisms of these alterations are still unclear, although the stimulation in the production of bioactive mediators in alveolar macrophages has been proposed (4 -6).Prostaglandins have been implicated as important modulators of various pathologic inflammatory and cardiovascular processes. The rate-limiting step in prostaglandin biosynthesis is the conversion of arachidonic acid to endoperoxides by cyclooxygenase enzymes, known to exist in two isoforms (7). The constitutive cyclooxygenase-1 (COX-1) is ubiquitously expressed and enrolled in physiologic processes, whereas the low basal activity of cyclooxygenase-2 (COX-2) can be stimulated by endogenous and exogenous mediators (7,8). Accordingly, COX-2 is activated in endotoxin and cytokinestimulated alveolar macrophages and pulmonary epithelial cells in vitro and this will result in the generation of large amounts of prostaglandin E 2 (8 -10). The activity of pulmonary prostaglandin synthesis after as...